Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA Monotherapy in HLA-Identical Kidney Transplant
NCT01053221Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Mar 2006
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolic acid in kidney transplant rejection, sponsored by University of Wisconsin–Madison. Started Mar 2006; status: terminated.
02
Drugs
mycophenolic acid
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01053221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053221.